The role of interleukin-17 and interleukin-23 inhibitors in the development, progression, and recurrence of cancer: A systematic reviewCapsule Summary

• Main Authors: Marie Vangilbergen, MD (Author), Aline Stockman, MD (Author), Axelle Van De Velde, MD (Author), Maria Garmyn, MD, PhD (Author), Kevin Punie, MD, PhD (Author), Tom Hillary, MD, PhD (Author)
• Format: Book
• Published: Elsevier, 2024-12-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: Biologicals targeting interleukin (IL)-17 and IL-23 improve quality of life in psoriasis and other chronic autoimmune disorders with a favorable safety profile. However, current guidelines do not recommend their use in patients with recent oncologic history due to limited evidence. Objec...